Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
135.42
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novo Nordisk A/S ADR
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
51
52
Next >
What's Going On With Eli Lilly Stock Wednesday?
October 11, 2023
Eli Lilly And Co (NYSE: LLY) shares are trading higher Wednesday.
Via
Benzinga
Why Eli Lilly Stock Is Jumping Today
October 11, 2023
Good news for Novo Nordisk's Ozempic could be good news for Lilly's Mounjaro.
Via
The Motley Fool
What's Going On With Kidney Dialysis Provider Stocks Today?
October 11, 2023
DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: BAX) shares fel
Via
Benzinga
Novo Nordisk Pops After Hinting Weight-Loss Drug Also Treats Kidney Disease
October 11, 2023
Semaglutide is the active ingredient behind three of Novo Nordisk's biggest products.
Via
Investor's Business Daily
Ozempic Is Moving a Bunch of Stocks Wednesday Morning
October 11, 2023
Find out who the winners and losers are.
Via
The Motley Fool
Google AI-Powered Chatbot's Ethical Concerns, MGM Hackers Waited For Days Before Issuing Financial Demands, Costco Accused Of Sharing Confidential Health Data With Facebook: Today's Top Stories
October 11, 2023
Bloomberg Google's AI Dilemma - Bard's Promise Versus Ethical Concerns
Via
Benzinga
Topics
Artificial Intelligence
Hacking
Exposures
Artificial Intelligence
Information Security
Is Novo Nordisk Stock a Buy Now?
October 11, 2023
Ozempic and Wegovy are changing the weight-loss game.
Via
The Motley Fool
Novo Nordisk Stops Semaglutide Kidney Outcome Trial Based On Early Signs Of Efficacy
October 11, 2023
Novo Nordisk A/S (NYSE: NVO) has decided to stop&
Via
Benzinga
Nasdaq, S&P 500 Set To Open Higher Ahead Of FOMC Minutes, Producer Price Inflation Data: Why This Analyst Braces For Better Market Performance Through Year-End
October 11, 2023
U.S. stocks look set to start higher Wednesday, potentially extending the gains into a fourth session amid hopes of a Fed pause.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
The Top 7 Stocks to Own During a Downturn
October 11, 2023
Investors tend to get jittery in October but these seven stocks to own during a downturn will protect your portfolio
Via
InvestorPlace
Wegovy Maker Novo Nordisk, Akero Therapeutics, Eli Lilly, Athena Consumer Acquisition, Tesla: Why These 5 Stocks Are Trending Today
October 10, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 130 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Is Ozempic Eating Into Snack Profits?
October 08, 2023
This week, Felix Salmon, Emily Peck, and Elizabeth Spiers talk about how Ozempic affects food buying habits, the rise in mortgage and interest rates, and the decrease in stock buybacks.
Via
Talk Markets
(NVO) - Analyzing Novo Nordisk's Short Interest
October 06, 2023
Via
Benzinga
WW Stock Soars To High. New Weight-Loss Drug Play Enjoys Oprah Winfrey Effect.
October 10, 2023
The ex WeightWatchers is reinventing itself amid boom for weight-loss drugs like Ozempic.
Via
Investor's Business Daily
Weight-Loss Drugs Aren't To Blame For The Snack Pullback. Pepsi Offers This Reason.
October 10, 2023
Weight-loss drugs aren't the reason for suppressed shopping cart spending in a shaky economy, Pepsi executives say.
Via
Investor's Business Daily
Topics
Economy
Exposures
Economy
Obesity Medication Insurance Coverage? Employers Embrace the Inclusion of Novo Nordisk's Wegovy in Health Coverage
October 10, 2023
Coverage for obesity medications, including Novo Nordisk A/S's (NYSE: NVO) Wegovy, is expected to expand among U.S.
Via
Benzinga
Why Eli Lilly Stock Crawled Higher Today
October 09, 2023
The pharmaceutical giant gets a lift from some good news on insurance coverage and a prognosticator's price-target lift.
Via
The Motley Fool
Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market
October 09, 2023
Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's (NYSE: NVO)...
Via
Benzinga
This Dividend Stock Just Got Hit With a Short Report. Is Now a Buying Opportunity?
October 08, 2023
Coca-Cola is the latest subject of the Bear Cave, an online publisher of reports on stock to sell short.
Via
The Motley Fool
3 Biotech Stocks Ready to Break Out in 2024
October 07, 2023
These top three biotech companies are ready to roar into the new year with promising new trials, drugs, and innovative use of AI.
Via
InvestorPlace
3 No-Brainer Growth Stocks to Buy in October
October 07, 2023
The time is right to invest in these great stocks.
Via
The Motley Fool
Shutdown Averted, Treasury Yields Flirt With 5%, Strong Payrolls Add to Fed Tightening Risk: The Week In The Markets
October 06, 2023
Catch up on the week's market highlights, from government funding drama to surging Treasury yields and an unexpectedly strong jobs report.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
October 06, 2023
Food and beverage stocks endure their toughest week since May 2022, driven by concerns over weight-loss drugs and shifting consumer behavior.
Via
Benzinga
Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories
October 06, 2023
Bloomberg Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger
Via
Benzinga
Better Growth Stock: Novo Nordisk vs. Pfizer
October 06, 2023
Which of these two pharmaceutical giants should you add to your portfolio?
Via
The Motley Fool
Novo Nordisk's Weight Loss Drugs Like Wegovy, Ozempic May Pose Serious Stomach Risks, Study Suggests
October 06, 2023
A recent study published in JAMA has raised concerns about the potential risks associated with popular weight loss and diabetes drugs like Novo Nordisk A/S's (NYSE: NVO), Wegovy (semaglutide), Ozempic...
Via
Benzinga
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
October 06, 2023
Eli Lilly's drug looks better on paper, but Ozempic was on the market first.
Via
The Motley Fool
ConAgra's Snack Revolution - Portion Sizes May Get A Makeover Amid Diet Drug Wave: Report
October 06, 2023
ConAgra Brands, Inc. (NYSE: CAG) could reportedly revamp the portion sizes of its snacks should the rising tide of
Via
Benzinga
Why Insulet Stock Traded Lower
October 05, 2023
Insulet Corporation (NASDAQ: PODD) shares traded lower Thursday.
Via
Benzinga
Biggest Oil Drop In A Year On Biden Security Plan, Magnificent 7 Stocks Do Not Like The New Data
October 05, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.